Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Photobiomodulation on Core Symptoms of Autism

NCT: NCT07542899 · NOT_YET_RECRUITING

NCT IDNCT07542899
StatusNOT_YET_RECRUITING
Start Date2026-04-10
Completion2026-08-10

Brief Summary

This study aims to evaluate the effectiveness of photobiomodulation therapy on core symptoms in children with autism spectrum disorder. Participants will receive designed physical therapy, occupational therapy and speech program in addition to Photobiomodulation over a defined period. Out comes will be assessed using standardized clinical scales to determine improvements in social interactions, communication and behavior.

Frequently Asked Questions

What is Photobiomodulation on Core Symptoms of Autism?

Photobiomodulation on Core Symptoms of Autism is a clinical trial registered under NCT07542899. Current status: NOT_YET_RECRUITING.

What is the status of NCT07542899?

The current status of NCT07542899 (Photobiomodulation on Core Symptoms of Autism) is: NOT_YET_RECRUITING.

When did Photobiomodulation on Core Symptoms of Autism start?

Photobiomodulation on Core Symptoms of Autism started on 2026-04-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.